ClinicalTrials.Veeva

Menu

Articaine 4% Efficacy and Safety in Extraction and Pulpotomy of Primary Molars of Children Below the Age of Four Years

M

Mahmoud Ahmed Mahmoud

Status

Unknown

Conditions

Behavior
Pain

Treatments

Drug: Articaine chloride 4% with epinephrine
Drug: Lidocain hydrochloride 2 % with epinephrine

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

compare the anaesthetic efficacy and safety for pain and behaviour for extraction or pulp therapy in primary molars in young children below four years old using 4% articaine and 2% lidocaine local anesthetics.

Enrollment

292 estimated patients

Sex

All

Ages

3 to 6 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Healthy children
  • 3-6 years
  • primary molar indicated for pulpotomy
  • body weight not less than 15 Kg

Exclusion criteria

  • Intellectual problem
  • sever emotional problems
  • previous dental experience
  • Medically or mentally compromised children

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

292 participants in 2 patient groups

Lidocaine
Active Comparator group
Description:
Lidocain hydrochloride 2 %with epinephrine 1:100000
Treatment:
Drug: Lidocain hydrochloride 2 % with epinephrine
Articaine
Experimental group
Description:
Articaine chloride 4% with epinephrine 1:100000
Treatment:
Drug: Articaine chloride 4% with epinephrine

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems